Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Annie Vermersch"'
Autor:
Catherine Droitcourt, Sébastien Barbarot, Annabel Maruani, Laure Darrieux, Laurent Misery, Emilie Brenaut, Henri Adamski, Cécile Chabbert, Annie Vermersch, Marie Weiborn, Julien Seneschal, Alain Taïeb, Patrice Plantin, Hervé Maillard, Alice Phan, François Skowron, Manuelle Viguier, Delphine Staumont-Salle, Audrey Nosbaum, Angèle Soria, Annick Barbaud, Emmanuel Oger, Alain Dupuy, Groupe de Recherche sur l’Eczéma Atopique de la Société Française de Dermatologie (GREAT)
Publikováno v:
Trials, Vol 20, Iss 1, Pp 1-11 (2019)
Abstract Background Atopic dermatitis is a highly prevalent, chronic, relapsing disease in both adults and children. On the severity spectrum, lower-end patients benefit from small amounts of topical anti-inflammatory treatments (TAT), whereas higher
Externí odkaz:
https://doaj.org/article/48163d29d5eb45428527d785addcb5b6
Autor:
Céline Phan, Nathalie Beneton, Juliette Delaunay, Ziad Reguiai, Claire Boulard, Anne-Claire Fougerousse, Elisa Cinotti, Marco Romanelli, Laure Mery-Bossard, Domitille Thomas-Beaulieu, Josiane Parier, François Maccari, Jean-Luc Perrot, Mireille Ruer-Mulard, Marie Bastien, Edouard Begon, Mahtab Samimi, Caroline Jacobzone, Nathalie Quiles-Tsimaratos, Vincent Descamps, Maud Steff, Paul Bilan, Annie Vermersch-Langlin, Mathilde Kemula, Emmanuelle Amazan, Ingrid Kupfer-Bessaguet, Anne-Caroline Cottencin, Francesca Prignano, Bulai Livideanu, Jeremy Gottlieb, Alain Beauchet, Emmanuel Mahé
Publikováno v:
Acta Dermato-Venereologica, Vol 100, Iss 18, p adv00316 (2020)
Anti-interleukin-17 agents have recently been developed for the treatment of psoriasis. This study evaluated the tolerance and effectiveness of anti-interleukin-17 agents for psoriasis in elderly patients in daily practice. A multicentre, retrospecti
Externí odkaz:
https://doaj.org/article/7a398feddaad430dba5a4a56efd6b03c
Autor:
Adrien Sanchez, Constance Mayslich, Isabelle Malet, Philippe Alain Grange, Michel Janier, Julie Saule, Pervenche Martinet, Jean-Luc Robert, Dominique Moulene, François Truchetet, Anne-Lise Pinault, Annie Vermersch-Langlin, Nadjet Benhaddou, Johan Chanal, Nicolas Dupin
Publikováno v:
Acta Dermato-Venereologica, Vol 100, Iss 14, p adv00221 (2020)
Benzathine penicillin G (BPG) is the reference treatment for early syphilis, but shortages have recently been reported, highlighting a need for the validation of alternative treatments. The aim of this study was to evaluate the genomic resistance of
Externí odkaz:
https://doaj.org/article/cf1f760b62e14452bf22ddf313e43254
Autor:
Petra Pospíšilová, Philippe Alain Grange, Linda Grillová, Lenka Mikalová, Pervenche Martinet, Michel Janier, Annie Vermersch, Nadjet Benhaddou, Pascal Del Giudice, Isabelle Alcaraz, François Truchetet, Nicolas Dupin, David Šmajs
Publikováno v:
PLoS ONE, Vol 13, Iss 7, p e0201068 (2018)
Treponema pallidum subsp. pallidum, the causative agent of sexually transmitted syphilis, detected in clinical samples from France, was subjected to molecular typing using the recently developed Multilocus Sequence Typing system. The samples (n = 133
Externí odkaz:
https://doaj.org/article/577e5504080f4ccf995cf1540f2f4299
Autor:
Karine Faure, Isabelle Alcaraz, Pierre Marcant, Sophie Duvert-Lehembre, Sarah Faiz, Edouard Massip, Annie Vermersch, Delphine Staumont-Sallé, Fanny Vuotto, Guillaume Font, Camille Macaire, Marie Véron, F. Dezoteux
Publikováno v:
Annales de Dermatologie et de Vénéréologie-FMC
Introduction Les manifestations cutanees possiblement liees a la Coronavirus Disease 19 (COVID-19) ont ete rapportees des printemps 2020. Nous observons desormais des reactions cutanees aux vaccins anti-COVID-19, impliquant les dermatologues dans le
Publikováno v:
European Journal of Dermatology. 30:322-323
Publikováno v:
European Journal of Dermatology. 27:86-88
Bullous drug eruptions are infrequent and potentially serious situations. Bullae are characteristic of two main diagnoses: the spectre of toxic epidermal necrolysis (TEN), the most serious, and the bullous fixed drug eruption (FDE); even if other sev
Autor:
Aurélie Jacobsoone, Annie Vermersch, Johana Béné, Anne-Fleur Tronquoy, Marlène Vonarx, Marine Auffret, Dominique Hillaire-Buys, Patrick Coupe, Samy Babai, Sophie Gautier, Marie-Josèphe Jean-Pastor
Publikováno v:
Fundamental and Clinical Pharmacology
Fundamental and Clinical Pharmacology, Wiley, 2015, 29 (1), pp.112-114. ⟨10.1111/fcp.12083⟩
Fundamental & Clinical Pharmacology
Fundamental & Clinical Pharmacology, 2015, 29 (1), pp.112-114. ⟨10.1111/fcp.12083⟩
Fundamental & Clinical Pharmacology, Wiley, 2015, 29 (1), pp.112-114. ⟨10.1111/fcp.12083⟩
Fundamental and Clinical Pharmacology, Wiley, 2015, 29 (1), pp.112-114. ⟨10.1111/fcp.12083⟩
Fundamental & Clinical Pharmacology
Fundamental & Clinical Pharmacology, 2015, 29 (1), pp.112-114. ⟨10.1111/fcp.12083⟩
Fundamental & Clinical Pharmacology, Wiley, 2015, 29 (1), pp.112-114. ⟨10.1111/fcp.12083⟩
International audience; To report three cases of bullous pemphigoid in patients treated with vildagliptin. Case 1: An 86-year-old woman presented with bullous pemphigoid after 1 month of treatment with vildagliptin and metformin. After introduction o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5048a6fbbb5a64c6f7c72ae98e61fc59
https://hal.umontpellier.fr/hal-02279576
https://hal.umontpellier.fr/hal-02279576
Publikováno v:
JAAD Case Reports
Ustekinumab, a monoclonal antibody that blocks interleukin-12 and interleukin-23, is a biological therapy used to treat moderate-to-severe psoriasis. Bullous pemphigoid (BP) induced by anti–tumor necrosis factor-alfa (TNF-α) agents has been descri
Autor:
Christine Burty, Thierry May, Simona Pavel, Kamel Ghomari, Jean Pouaha, Christian Rabaud, Yazdan Yazdanpanah, Annie Vermersch, Bernard Christian
Publikováno v:
Journal of acquired immune deficiency syndromes (1999). 49(3)